Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whether human β cell dysfunction induced by metabolic stress is reversible, evaluate the molecular pathways underlying persistent or transient damage, and explore the relationships with T2D islet traits. Twenty-six islet preparations are exposed to several lipotoxic/glucotoxic conditions, some of which impair insulin release, depending on stressor type, concentration, and combination. The reversal of dysfunction occurs after washout for some, although not all, of the lipoglucotoxic insults. Islet transcriptomes assessed by RNA sequencing and expression quantitative trait loci (eQTL) analysis identify specific pathways underlying β cell failure a...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Pancreatic β cell failure is key to type 2 diabetes (T2D) onset and progression. Here, we assess whe...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
Marselli et al. find that human β cell dysfunction induced by metabolic stresses is persistent or tr...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
β-cell dysfunction is central to the onset and progression of type 2 diabetes. Reduced islet number ...
Type 2 diabetes (T2D) is caused by insufficient insulin secretion from pancreatic β-cells. To identi...